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Background: Chicken red blood cells (RBCs) are commonly used in hemagglutination inhibition (HI) tests to
measure hemagglutinating antibodies against influenza viruses. The use of horse RBCs in the HI test can reportedly
increase its sensitivity when testing human sera for avian influenza antibodies. This study aims to compare the
proportion of positives detected and the agreement between two HI tests using either chicken or horse red blood
cells for antibody detection in sera of ducks experimentally infected or naturally exposed to Indonesian H5 subtype
avian influenza virus. In addition, comparison with a virus neutralisation (VN) test was conducted with the
experimental sera.
Results: In the experimental study, the proportion of HI antibody-positive ducks increased slightly, from 0.57 when
using chicken RBCs to 0.60 when using horse RBCs. The HI tests indicated almost perfect agreement (kappa = 0.86)
when results were dichotomised (titre≥ 4 log2), and substantial agreement (weighted kappa = 0.80) for log titres.
Overall agreements between the two HI tests were greater than between either of the HI tests and the VN test. The
use of horse RBCs also identified a higher proportion of antibody positives in field duck sera (0.08, compared to
chicken RBCs 0.02), with also almost perfect agreements for dichotomized results (Prevalence and bias adjusted
Kappa (PABAK) = 0.88) and for log titres (weighted PABAK = 0.93), respectively. Factors that might explain observed
differences in the proportion of antibody-positive ducks and in the agreements between HI tests are discussed.
Conclusion: In conclusion, we identified a good agreement between HI tests. However, when horse RBCs were
used, a higher proportion of sera was positive (titre≥ 4 log2) than using chicken RBCs, especially during the early
response against H5N1 virus. The HRBC-HI might be more responsive in identifying early H5N1 HPAI serological
response and could be a recommended assay for avian influenza sero-surveillance in both wild and domestic birds.
Keywords: Avian influenza, H5N1, Hemagglutination inhibition test, Virus neutralization test, Horse red blood cells,
Duck, KappaBackground
The spread of the Eurasian lineage of H5N1 highly patho-
genic avian influenza (HPAI) from China to other countries
across Asia, Europe, the Middle East, and Africa is an un-
precedented epizootic event. Although the initial outbreaks
of H5N1 HPAI virus in Hong Kong, China, were success-
fully eradicated in late 1997 [1], the virus re-emerged in* Correspondence: j.henning@uq.edu.au
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reproduction in any medium, provided the or2001 and 2002 causing HPAI outbreaks with high mortal-
ities of chickens on commercial farms [1] and deaths of mi-
gratory birds and waterfowl, including ducks, in two local
parks in Hong Kong [2]. At least three waves of H5N1
HPAI spread then occurred [3]: firstly, to East Asia and
Southeast Asia between 2003 and 2004 [4,5]; secondly,
from Qinghai Lake, China, to South Asia, Europe, the
Middle East, and Africa between 2005 and 2006 [5,6]; and
thirdly, to South Asia and Southeast Asia again between
2007 and 2009 [7-10].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of H5N1 HPAI viruses in many countries, and the
catastrophic impacts to both poultry and human
health [3], rapid and sensitive diagnostic methods are
very important for early detection of H5N1 disease
outbreaks. The haemagglutination inhibition (HI) test
is one such method, being relatively quick to perform
and widely regarded as a reliable method for the de-
tection of antibodies to influenza viruses. The HI test
relies on the inhibition of the interaction between the
viral hemagglutinin (HA) glycoprotein and sialic acid
receptors on the surface of red blood cells (RBCs) by
antibodies which are directed against the HA receptor
binding pocket [11]. This test is a simple and inex-
pensive technique utilizing standard laboratory equip-
ment, and can be used for identification of avian
influenza virus subtypes as well as for measuring HA
specific antibodies to the virus [12]. For these rea-
sons, the HI test has been used extensively in epi-
demiological studies of influenza virus [13]. Some
studies [14-16] have shown that the HI tests, using
various types of RBCs, were less sensitive than the
virus neutralization (VN) tests in detecting the anti-
body response of humans who were naturally exposed
to influenza viruses. In contrast, others reported that
in some circumstances, the HI test using horse or
goose RBCs could be more sensitive than the
neutralization test [17]. These disparate findings sug-
gest that the sensitivity of serology tests can be vari-
able, and may depend on the particular materials or
methods that are used.
The sensitivity of the HI test for detection of anti-
bodies against avian influenza viruses in human sera
can be improved by replacing avian RBCs with equine
RBCs within the test [13,14,17-19]. An experimental
study using sera of gallinaceous birds, pheasants and
chukar partridges, revealed that HI-antibody titres that
were detected by using horse RBCs were more compar-
able to neutralizing antibody titres than those from HI
tests using chicken RBCs [20]. None of these studies
has tested serum samples from aquatic birds, such as
domestic ducks, which are considered to play an im-
portant role in the H5N1 HPAI virus maintenance and
spread [21-23]. Since the avian influenza antibody titres
of ducks are reportedly low when measured by the
traditional HI test based on chicken RBCs [24,25], we
hypothesised that the use of horse RBCs could influ-
ence the performance of the HI test. We tested sera
from ducks experimentally inoculated and naturally
exposed in the field to Indonesian H5 subtype virus
using HI tests based on both chicken (HI-CRBC) and
horse RBCs (HI-HRBC) and using a virus neutralisation
(VN) test for sera from the experimentally infected
ducks.Methods
Sera
The studies were conducted on the two different groups
of serum samples (experimental and field) at two differ-
ent laboratories: Australian Animal Health Laboratory
(AAHL), Geelong, Australia and Disease Investigation
Centre (DIC) Wates, Yogyakarta, Indonesia, respectively.
Sixty serum samples were collected from experimen-
tally infected ducks (N = 10) at six sampling times: 4 days
prior to the virus inoculation and 8, 15, 22, 29 and
34 day post inoculation (dpi). The results of a blocking
enzyme-linked immunosorbent assay showed that none
of these ducks had pre-exposure to avian influenza (AI)
virus subtypes. Each duck was inoculated via nostrils,
eyes and mouth with 0.5 ml of inoculum containing
108.4 50% egg lethal doses of an Indonesian clade 2.1.1
H5N1 virus, A/duck/Sleman/BBVW-1003-34368/2007
(IDN34368), derived from infected allantoic fluid and
diluted in sterile phosphate-buffered saline (PBS). The
trial was approved by the CSIRO-AAHL Animal Ethics
Committee. The tests on experimentally-derived sera
were conducted at microbiological physical containment
level 3 at AAHL.
Field sera were collected in a longitudinal study con-
ducted to estimate HPAI prevalence in farmed duck
populations [26]. In this study, 54 “moving” duck flocks
in 6 districts of Central Java, Indonesia, were sampled at
monthly intervals between November 2008 and April
2009 [26]. The highest bird-level seroprevalence was
observed in December 2008. Therefore, December 2008
represented the month with the largest range of HI titres
and serum samples collected in this month were used
for the current study. Sera from a total of 518 ducks
were available and were tested at the DIC Wates. From
all ducks also cloacal and an oropharyngeal swabs were
collected. The swab samples were then tested at the DIC
Wates in pools of five for subtype H5 virus RNA using
influenza RT-PCR as described in an earlier study [27].
All pools of our study birds tested H5 virus RNA
negative.
HI tests
For HI tests conducted at AAHL on experimental duck
sera, antigen of the same virus isolate used in the inocu-
lation was used in the tests. Chicken blood in EDTA was
obtained from the small animal facility at AAHL and
horse blood in Alseiver’s solution was obtained from the
Institute of Medical and Veterinary Science, Adelaide,
Australia. For HI tests conducted at DIC Wates on field-
derived sera, antigen of another Indonesian 2.1.1 clade
virus, A/chicken/Legok/2003 (H5N1) was used in the
tests. Chicken and horse blood, both in Alseiver’s solu-
tion, were obtained from chickens housed at DIC and
from PT Bio Farma, Bandung, Indonesia, respectively.
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PBS (pH 7.2-7.3) and prepared as 10% RBCs stock solu-
tion. In both studies, serum from the blood donor chick-
ens or horses was confirmed to be H5 antibody negative
before use in the HI tests.
The sera from both the experimental and field studies
were heat inactivated for 1 hour at 56°C before use. It is
not necessary to treat duck sera with receptor destroying
enzymes, because sera from the majority of avian species
do not contain nonspecific inhibitors [12,28]. However,
sera from species other than chickens may sometimes
cause non-specific agglutination of chicken RBCs [28]
and possibly of other species RBCs. Prior adsorption of
avian sera with the RBCs that are used in the HI test can
remove these non-specific agglutinins [12,28,29]. Thus,
prior to the tests, 50 μl of each duck serum sample was
adsorbed with 50 μl of 10% chicken RBCs in PBS or with
50 μl of 10% horse RBCs in PBS containing 0.5% bovine
serum albumin (BSA [Sigma Aldrich]) in 96-well U-
bottom microtiter plates, incubated at 4°C for 1 hour
and gently mixed periodically. Here, the sera were
regarded as a 1:2 dilution of the original serum samples.
After the incubation, RBCs were pelleted by centrifuga-
tion at 800 g for 5 minutes. The adsorbed sera were
removed, then 25 μl was transferred to the first column
wells of another microtitre plate containing 25 μl PBS
(for HI-CRBC) or PBS + 0.5% BSA (for HI-HRBC). This
means that these sera were further diluted 1:2 at the
start of the HI test, therefore the minimal detectable
titre given by the HI tests was 4 (2 log2). The HI tests
were performed with 0.5% chicken RBCs in PBS or with
1% horse RBCs in PBS + 0.5% BSA using 4 haemaggluti-
nating units (HAU) of antigen per well as described pre-
viously [14,30]. Reference positive serum (from
immunized specific-pathogen free [SPF] chickens with
A/chicken/Indonesia/Wates1/2005 H5N1 antigen) and
negative serum (from uninfected SPF chickens) were
included on each run of the test. The HI titre was
expressed as the reciprocal value of the highest dilution
of serum causing complete inhibition of agglutination of
4 HAU antigen. To dichotomize positive from negative
results, HI titres of 16 (4 log2) or greater were classified
as positive for avian influenza antibody, according to
OIE guidelines [28].
VN test
The VN test was performed on the experimentally-
derived sera. Initially, 50 μl of cell culture media con-
taining EMEM (Invitrogen) with HEPES solution,
glutamine, penicillin and streptomycin, and fungizone
(all antibiotics from Sigma Aldrich) was added to all
wells of a 96-well microtitre plate. Sera were firstly
diluted 1:2 in sterile PBS; then 50 μl of each diluted
serum was added each into the wells of the first andsecond column of microtitre plates. Starting from the
wells in the second column, two-fold dilutions of 50 μl
volumes of sera were performed across the plate, then
the excess of 50 μl volumes were discarded after the last
wells. The same positive and negative control sera as HI
tests were diluted in the same way. The virus stock
(IDN34368) was diluted to contain 100 TCID50/50 μl,
and 50 μl was added to all wells containing diluted sera,
except for the first wells which served as serum controls.
Plates were incubated at 37°C, in 5% CO2, for 1 hour,
then 100 μl Vero cells suspension containing approxi-
mately 2–4 × 105 cells/ml in culture media with 10%
foetal calf serum (Invitrogen) was added to all wells of
the plates and the plates were incubated at 37°C in 5%
CO2. A back titration of diluted virus was performed
with every test run to confirm the concentration of virus
used in the test. The VN plates were examined for cyto-
pathic effect (CPE) using an inverted microscope after
5 days incubation. The neutralization titre was expressed
as the reciprocal value of the highest serum dilution at
which viral CPE was not observed. For consistency with
the HI test results, any serum with neutralizing antibody
titre of 16 (4 log2) or greater was considered as positive.
Statistical analysis
For the samples obtained in the experimental study, we
calculated the proportion of positive test results for each
serological test (HI-CRBC, HI-HRBC, VN) at each sam-
pling, including the 95% binominal exact confidence
intervals for each sampling period [31]. We also calcu-
lated the overall proportion of positive test results for
each serological test and the 95% confidence interval. As
the same birds were repeatedly tested at different sam-
pling periods, repeated observations of birds in the over-
all calculation were considered by accounting for a
clustering of birds by sampling period [32]. This resulted
in the adjustment of standard errors and thereby adjust-
ment of confidence intervals. For the samples collected
in the field study, we calculated the proportion of posi-
tive test results for the two serological tests used
(HI-CRBC, HI-HRBC) and the 95% confidence interval.
Some birds were obtained from the same farms; there-
fore we considered a clustering of birds by duck farms
and adjusted the standard errors and confidence inter-
vals for this intra-farm correlation [32].
The agreement of dichotomised test results between
two tests was assessed using the kappa (κ) statistic. As a
tendency of one test identifying more positives than an-
other test influences the kappa statistic, we used the
McNemar test for paired data to evaluate the proportion
of positives identified between the two tests [33]. A sig-
nificant result indicated the existence of bias, i.e. that
the proportion of positives differed between tests, and in
these cases we calculated an additional measurement of
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(PABAK). PABAK considers the described bias and also
the underlying prevalence, which affects the (unadjusted)
kappa statistic. The PABAK is calculated as 2*observed
agreement-1 [34].
The agreement between the actual log titres of two
serological tests was assessed using a weighted kappa.
Thereby a pair of log titres with titre values closer to
each other was considered to be more in partial agree-
ment than a pair of log titres, with titre values further
apart [33]. Confidence intervals for the kappa statistic of
the dichotomised test results were calculated using the
analytic method [35] and the bootstrap method with 100
bootstrap replication was used to calculate the confi-
dence intervals for the weighted kappa agreement of the
log titers [36,37].
The kappa values were interpreted as the following:
≤ 0 poor agreement, 0.01-0.20 slight agreement, 0.21-
0.40 fair agreement, 0.41-0.60 moderate agreement,
0.61-0.80 substantial agreement and 0.81-1.0 almost
perfect agreement [38]. All calculations were conducted




Not all ducks became antibody positive following the in-
oculation of H5N1 virus, as determined by the three
serological tests (Table 1). The results of HI tests, using
either chicken or horse RBCs, showed that only 8 of 10
ducks became antibody positive over the 34-day post-
inoculation period, while the VN test showed 9 of 10
ducks became antibody positive. At the earliest sampling
(8 dpi), the proportion of antibody-positive ducks by HI-
HRBC (0.70, 95%-CI 0.35-0.93) was greater than theTable 1 Number and proportion of serum samples testing H5
experimentally infected with H5N1
Test results Pre-inoculation 8 dpi 15 dpi
N HI-CRBC pos 0 4 8
Prop HI-CRBC pos 0 0.4 0.8
(95%-CI)1,2 (0–0.31) (0.12-0.74) (0.44-0.98
N HI-HRBC pos 0 7 8
Prop HI-HRBC pos 0 0.7 0.8
(95%-CI)1,2 (0–0.31) (0.35-0.93) (0.44-0.98
N VN pos 0 2 8
Prop VN pos 0 0.2 0.8
(95%-CI)1,2 (0–0.31) (0.03-0.56) (0.44-0.98
A titre cut-off of≥ 4 log2 (16) was used to distinguish between positive and negativ
34 days after virus inoculation. Abbreviations: HI-CRBC (Haemagglutination inhibitio
test using horse red blood cells), VN (Virus neutralisation test), N (number), Prop (pr
1Binominal exact confidence intervals were calculated for the proportion of positive
2Confidence intervals for the overall proportion of positives were adjusted for a cluproportions of antibody-positive ducks by either HI-
CRBC (0.40, 95%-CI 0.12-0.74) or VN (0.20, 95%-CI
0.03-0.56). All ducks testing positive at 8 dpi remained
positive at the later sampling times. At 15 dpi, all three
serology tests showed an identical proportion of ducks
being H5 antibody-positive (0.80, 95%-CI 0.44-0.98). Al-
though at the end of the experiment (34 dpi) the results
of both HI tests revealed similar proportions of
antibody-positive ducks (0.70, 95%-CI 0.35-0.93), a
higher proportion of antibody-positive ducks was
observed in the VN test (0.90, 95%-CI 0.55-1.00). All
serum samples tested positive in the test with the least
number of positives at any sampling time, were also
positive by the other two tests at the same sampling
time; for example, two sera that were positive at 8 dpi in
the VN test were also positive in both HI tests at the
same sampling. Over the entire sampling period, the HI-
HRBC test detected only slightly more ducks as being
antibody-positive (0.60, 95%-CI 0.33-0.87) than either
the HI-CRBC test (0.57, 95%-CI 0.33-0.81) or the VN
test (0.58, 95%-CI 0.40-0.76) (Table 1).
The McNemar test was not significant at p< 0.05 for
comparisons of the proportion of positives between two
serological tests at any sampling period (except at 8 dpi
between HI-HRBC and VN) or overall. Therefore, the
kappa statistic was appropriate to evaluate the agree-
ment of test results in the experimental study. Overall
agreements between the two HI tests were greater than
between each HI test and the VN test (Table 2). The
kappa statistics for the overall dichotomised results be-
tween the HI tests indicated almost perfect agreement
(κ= 0.86, 95%-CI 0.73-0.99), while substantial agree-
ments were seen in both kappa statistics between HI-
CRBC and VN (κ= 0.76, 95%-CI 0.60-0.93) and between
HI-HRBC and VN (κ= 0.69, 95%-CI 0.50-0.88). Betterantibody positive in three serological tests in ducks
22 dpi 29 dpi 34 dpi Overall
8 7 7 34
0.8 0.7 0.7 0.57
) (0.44-0.98) (0.35-0.93) (0.35-0.93) (0.33-0.81)
7 7 7 36
0.7 0.7 0.7 0.60
) (0.35-0.93) (0.35-0.93) (0.35-0.93) (0.33-0.87)
8 8 9 35
0.8 0.8 0.9 0.58
) (0.44-0.98) (0.44-0.98) (0.55-1.00) (0.40-0.76)
e results. Ten ducks were sampled before inoculation and at 8, 15, 22, 29 and
n test using chicken red blood cells), HI-HRBC (Haemagglutination inhibition
oportion), dpi (day post inoculation), CI (confidence interval).
s at each sampling period.
stering of birds by sampling period (10 clusters).
Table 2 Agreement between three serological tests used for the detection of H5 antibodies in ducks experimentally
infected with H5N1
Test comparison 8 dpi 15 dpi 22 dpi 29 dpi 34 dpi Overall
Kappa
HI-CRBC and HI-HRBC:










































































Ten ducks were sampled before inoculation with H5N1 virus and at 8, 15, 22, 29 and 34 days post inoculation (dpi). The kappa statistic (95% confidence interval1)
was used to compare dichotomised test results (positive versus negative) and a weighted kappa statistic (95% confidence interval2) was used to compare log
titers at each sampling period and across all sampling periods.
1The analytical method was used to calculate confidence intervals for dichotomised test results [35].
2The bootstrap method with 100 bootstrap replications was used to calculate confidence intervals for the log titers [36,37].
Abbreviations: HI-CRBC (Haemagglutination inhibition test using chicken red blood cells), HI-HRBC (Haemagglutination inhibition test using horse red blood cells),
VN (Virus neutralisation test), CI (confidence interval).
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weighted kappa values for the comparison of actual log
titres between HI tests than the overall weighted kappa
values between each HI and the VN test. When HI tests
were compared at different sampling intervals, reduced
agreements for dichotomised results (κ= 0.44, 0.55, and
0.19) and for the log titre results (weighted κ= 0.56,
0.49, and 0.19) were observed for the test comparisons
at the beginning of the trial (8 dpi) (Table 2). However,
better agreements were found between the HI tests
results for the sera collected at the later samplings at 15,
22, 29 and 34 dpi.
We tried to identify at what titres and at which days after
inoculation discrepancies between test results were found.
Discrepancies in the actual log titres for the same sera
tested with different HI tests were observed at low and high
log HI-CRBC titres (Table 3). For example, three duck sera
showed a positive titre (5 log2) in the HI-HRBC, but were
all negative (< 4 log2) when tested using the HI-CRBC. For
HI-CRBC, only 40-50% of serum samples with titres of 7
log2 and 6 log2 had matching HI-HRBC titres (Table 3).
Field study
Although the experimental study provided a complete data-
set for the assessment of HI titers from individual ducks
monitored over six sampling periods, the birds in that study
were knowingly infected with H5 subtype virus. In order to
assess sera of unknown infection status, we conducted a
comparison of HI tests with sera from farmed ducks inIndonesia. Due to the limited quantity of some of the field
sera, only the two HI tests (HI-HRBC and HI-CRBC) could
be performed on these samples.
When the HI test results were dichotomised, more duck
sera were detected as antibody-positive using HI-HRBC
(41 of 518) than using the HI-CRBC test (11 of 518); and
no samples that were positive with HI-CRBC were negative
with HI-HRBC (Table 4). Thus, the proportion of ducks
being positive was higher when the HI-HRBC test was used
(0.08, 95%-CI 0.03-0.12) than when the HI-CRBC was used
(0.02, 95%-CI 0.00-0.04) (McNemar test: Chi2 = 30.0,
P< 0.001) (Table 5). Hence, we calculated in addition to
the unadjusted kappa, the PABAK to evaluate the agree-
ments between the two HI tests. Using PABAK almost per-
fect levels of test agreement between the two HI tests were
indicated for the dichotomised results (0.88) and for the
log2 titres (0.94), while the unadjusted kappa indicated only
fair (0.40) to moderate (0.53) agreements (Table 5). Dis-
crepancies were also found in the actual titre values in the
same sera tested with different HI tests. Some sera had high
titres of 6 or 8 log2 by HI-HRBC, but showed low titres or
were negative (< 4 log2) by HI-CRBC (Table 6). Overall,
when bias and prevalence adjustments were considered,
agreements between tests were similar to those yielded
from the experimental study.
Discussion
This study presents the first report of employing horse
RBCs in the HI test for detecting antibodies against H5
Table 3 Matrix indicating the number and percentage of log antibody titres obtained in two HI tests after
experimental infection of ducks with H5N1
HI-HRBC log titres
HI CRBC log titres <2 2 3 4 5 6 7 8 N Total (%)
<2 16 0 0 1 0 0 0 15 (28.3)
2 0 0 2 0 1 0 0 0 4 (5.0)
3 0 2 3 0 1 0 0 0 6 (10.0)
4 0 0 1 0 0 0 0 0 1 (1.7)
5 0 0 0 1 2 0 0 0 3 (5.0)
6 0 0 0 0 3 7 4 0 14 (23.3)
7 0 0 0 0 1 5 4 0 10 (16.7)
8 0 0 0 0 0 0 4 2 6 (10.0)
N Total (%) 16 (26.7) 2 (3.3) 6 (10.0) 1 (1.7) 9 (15.0) 12 (20.0) 12 (20.0) 2 (3.3) 60
Ten ducks were inoculated with H5N1 virus and were sampled before inoculation and at 8, 15, 22, 29 and 34 days post inoculation. HI titers are expressed as the
log2 value of the reciprocal of the highest dilution causing inhibition of haemagglutination. The lowest detectable antibody titre was 2 log2; thus, any sera with
titres below this were classified as<2 log2. HI titres of =4 log2 were classified as positive. Abbreviations: HI-CRBC (Haemagglutination inhibition test using chicken
red blood cells), HI-HRBC (Haemagglutination inhibition test using horse red blood cells), N (number).
Table 5 Proportion of serum samples testing antibody
positive and agreement between two HI tests in ducks
naturally exposed to H5 avian influenza virus
HI-CRBC HI-HRBC
Proportion positive (95%-CI)1 0.02 (0.0-0.04) 0.08 (0.03-0.13)
Dichotimized results:
Kappa (95%-CI)2 0.40 (0.24-0.57)
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ered to play a major role in the maintenance of HPAI
H5N1 virus in Asia [21-23]. In both the experimental
and field studies, the HI-HRBC test detected a greater
number of sera as positive (titre ≥ 4 log2) than the HI-
CRBC test, but overall there was a very good agreement
between the HI tests. Previous studies have demon-
strated that performing HI tests using horse RBCs could
increase the detection of HI antibodies against avian in-
fluenza viruses in human sera [13,14,17-19]. Antibodies
to the viral HA glycoprotein inhibit binding of avian-
derived influenza viruses to their specific sialic acid re-
ceptor, which has a sialic acid, N-acetylneuraminic acid
α-2,3-galactose (SAα2,3Gal) linkage [19]. Horse RBCs
express predominantly SAα2,3Gal linkages, whereas
chicken RBCs express a mixture of SAα2,3Gal and
SAα2,6Gal linkages [39], which accounts for the higher
sensitivity of the avian influenza HI test using horse
RBCs compared to chicken RBCs.
The experimental study showed that the HI-HRBC
test was able to detect H5 antibodies at an earlier stageTable 4 Dichotomised results for two HI test used for the
detection of H5 antibodies in ducks naturally exposed to
H5 avian influenza virus
HI-HRBC results
HI-CRBC results Positive Negative Total
Positive 11 0 11
Negative 30 477 507
Total 41 477 518
Ducks were sampled in December 2008 in Central Java, Indonesia. A cut-off
titre of≥ 4 log2 (16) was used to distinguish between positive and negative
results. Abbreviations: HI-CRBC (Haemagglutination inhibition test using
chicken red blood cells), HI-HRBC (Haemagglutination inhibition test using
horse red blood cells).of serological response (8 dpi) than the HI-CRBC. At the
later stages of infection, both HI-CRBC and HI-HRBC
showed an equal dichotomised result. Better agreements
were found between the two HI tests than between each
HI test and the VN test, which might be due to differ-
ences in the binding specificities of antibodies detected
in each of the tests. HI tests detect antibodies that in-
hibit viral hemagglutination, whereas the VN test detects
antibodies that neutralize the virus and prevent replica-
tion in living cells [16]; not all antibody specificities that
inhibit hemagglutination necessarily neutralize the virus,PABAK 0.88
Log titers:
Weigthed Kappa (95%-CI)3 0.53 (0.45-0.62)
PABAK 0.94
A total of 518 ducks were sampled in December 2008. The kappa statistic
(95% confidence interval1) was used to compare dichotomised test results
(positive versus negative) and a weighted kappa statistic (95% confidence
interval2) was used to compare log titers.
1Confidence intervals for the proportion of positives were adjusted for
clustering of ducks by farm (54 clusters).
2The analytical method was used to calculate confidence intervals for
dichotomised test results [35].
3The bootstrap method with 100 bootstrap replications was used to calculate
confidence intervals for the log titers [36,37].
Abbreviations: HI-CRBC (Haemagglutination inhibition test using chicken red
blood cells), HI-HRBC (Haemagglutination inhibition test using horse red blood
cells), CI (confidence interval), PABAK (Prevalence and bias adjusted kappa).
Table 6 Matrix indicating the number and percentage of log antibody titers obtained in two HI tests in ducks naturally
exposed to H5 avian influenza virus
HI HRBC log titres
HI CRBC log titres <2 2 3 4 5 6 7 8 N Total (%)
<2 469 0 5 5 1 0 0 0 485 (93.6)
2 1 1 1 2 0 0 0 0 8 (1.5)
3 0 0 0 7 5 0 1 0 14 (2.7)
4 0 0 0 4 4 1 0 0 9 (1.7)
5 0 0 0 0 0 1 0 0 1 (0.2)
6 0 0 0 0 0 1 0 0 1 (0.2)
7 0 0 0 0 0 0 0 0 0 (0.0)
8 0 0 0 0 0 0 0 0 0 (0.0)
N Total (%) 470 (90.7) 1 (0.2) 6 (1.2) 9 (1.7) 18 (3.5) 10 (1.9) 3 (0.6) 1 (0.2) 518
Ducks were sampled in December 2008 in Central Java, Indonesia. A/chicken/Legok/2003(H5N1) antigen was used in both tests. HI titers are expressed as the log2
value of the reciprocal of the highest dilution causing inhibition of haemagglutination. The lowest detectable antibody titre was 2 log2; thus, any sera with titres
below this were classified as< 2 log2. Abbreviations: HI-CRBC (Haemagglutination inhibition test using chicken red blood cells), HI-HRBC (Haemagglutination
inhibition test using horse red blood cells), N (Number).
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inhibit hemagglutination caused by the virus [40].
The experimental study showed that not all inoculated
ducks developed either HI or neutralizing antibodies by
the end of the trial at 34 dpi. The virus may have failed
to successfully replicate at the entry point in eyes, nasal
or oral cavity of these antibody-negative ducks. Alterna-
tively, the virus may have replicated to some degree at
these mucosal entries, but was unable or had no chance
to stimulate a humoral response because of a strong in-
nate immune responses such as a rapid apoptosis mech-
anism [41] or RIG-I pathways [42]. Another possibility is
that these antibody-negative ducks developed low HI
and neutralizing antibody titres below the cut-off titre.
The OIE recommended cut-off titre of 4 log2 [28] was
used in this study for the dichotomization of test results.
A lower cut-off of 3 log2 would have resulted in nine
ducks classified seropositive by both HI tests instead of
eight. Using a slightly lower HI test cut-off titre may be
appropriate for the early detection of H5N1 HPAI ex-
posure in disease free regions, but further confirmatory
tests supported by epidemiological data on potential ex-
posure status of birds are required to avoid false positive
results. On the other hand, a cut-off of 4 log2 is perhaps
preferable for measuring the proportion of antibody
positives in countries where H5N1 HPAI is endemic and
major reservoirs of all AI subtypes might exist.
A large disparity in the seroprevalence results between
the two HI tests was demonstrated in the field sera.
Overall, significantly (P< 0.001) more HI antibody-
positive ducks were detected with HI-HRBC than HI-
CRBC, but no sera that were positive in the HI-CRBC
were negative in the HI-HRBC test. This indicates that
the type of HI test used for assessing field sera has to becarefully chosen as the test performance will influence
the reported measures of disease frequency, such as
prevalence or incidence, for the population evaluated. In
contrast a discrepancy between the proportions of posi-
tives identified with the HI tests was not evident in the
experimental study. Compared to the experimental
study, the H5N1-exposure status of ducks in the field
study was unknown. Therefore, it is possible that some
of the birds that tested negative in the HI-CRBC test
were in the early response of H5N1 infection, which as
the experimental study showed, is more likely to be
detected with the HI-HRBC test than HI-CRBC.
The interpretation of the diagnostic test results should
be conducted cautiously, particularly if it is performed to
assess an agreement between tests using samples from
different populations. The seroprevalence of ducks in
the field was relatively low (8% or 2% using HI-HRBC
and HI-CRBC, respectively) in contrast to the overall
seroprevalence of 57-60% obtained in the experimental
study. Factors related to the stage and severity of disease
and the immune status vary within a population (and
could be different in low- and high-prevalence popula-
tions) [43]. Therefore the distribution of individuals
sampled at different stages in the infection process will
influence the prevalence estimated. On the other hand,
it has been highlighted that the statistical relationship
between kappa and prevalence (and bias) is multifaceted
and complex [33,44,45]; two tests will have a higher
kappa value if the prevalence is moderate (e.g. 50%) ra-
ther than very low or very high [33]. Therefore the un-
adjusted kappa statistic was higher for the experimental
study compared to the field study. In fact, it has been
recommended by some statisticians to concentrate on
populations with prevalence near 50% when comparing
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measures such as the PABAK [45]. However, in reality
we often face situations with low or high prevalence
values and this was also the case in our field study.
Hence, we used the PABAK to evaluate the agreement
of HI tests conducted with field samples and noted a
similar agreement compared to tests conducted with
samples collected in the experimental study.
The variety of individuals in terms of breed and age
within the population are also important factors that
might influence the ability of biological assays to detect
infected and uninfected animals. The experimental study
used homogenous birds, while in the field study ducks
of genetically diverse breeds and of different ages were
sampled. In addition, given the possibility of other sub-
types of AI viruses circulating on duck farms, cross re-
activity could have been another factor influencing the
serological test results in the field study.
Adherence to recommend guidelines, such as the OIE
Manual of diagnostic tests and vaccines for terrestrial
animals [28], is essential to standardize diagnostic proce-
dures in different laboratories. For example, OIE has
recommended using RBCs from specific-pathogen or
specific-antibody free chickens for HI tests to detect
antibodies against AI viruses, including H5N1 HPAI [28]
and we did so in both our experimental and field study.
However, country-specific access to specific reagents
might influence laboratory specific test variability. In this
regard, our study might have had some limitations
related to the use of different sources of H5N1 antigen
and RBCs in the serological tests of sera between the
two studies. Since we used the same H5N1 virus lineage
(clade 2.1.1) for antigens, with 99.9% and 99.8% homolo-
gies detected in the hemagglutinin nucleotide and amino
acid sequences among both viruses respectively (only
one amino acid difference was found in a residue unre-
lated with either antigenic or glycosylation sites) [30], we
assume that the variations in the HI results are likely to
be related more to the exposure status and host-specific
factors of birds (e.g. age, breed) than the types of antigen
used.
It was beyond the scope and objective of this study
to estimate the sensitivity and specificity of the HI
tests, in particular in the absence of a gold standard
for detecting antibodies against avian influenza
viruses. Therefore, an assessment of HI test charac-
teristics through future studies is recommended.
Overall our finding support a previous study which
reported that the use of horse RBCs increased per-
formance of HI tests in measuring AI antibodies in
other bird species [20]. Thus, we suggest that the
OIE should review these findings for an alternative
serological method for the diagnosis and surveillance
of HPAI in birds.Conclusion
In summary, we identified a good agreement between HI
tests. However, the HI test using horse RBCs detected a
higher proportion of sera as positive (titre ≥ 4 log2) than
the conventional HI test based on chicken RBCs, par-
ticularly during the early response against H5N1 virus.
Both HI techniques are reasonable methods for AI sero-
surveillance, but the HRBC-HI might be more respon-
sive in identifying the early stage of a H5N1 HPAI
serological response.
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